The Institute for Cancer Research (ICR) conducts cutting edge cancer research ranging from basic cancer biology to translational and clinical research. It is the leading cancer research institute in Norway and has a strong international standing. ICR is organized in 6 research departments, currently with 26 research groups, approx. 380 employees and an annual output of approximately 200 peer reviewed publications. Particularly strong research areas are cancer genetics, cell biology, cancer progression and metastasis biology, biomarker discovery and development, radiation biology, cancer immunology and systems biology. ICR hosts a department for core facilities including NGS/genomics platforms, bioinformatics, flow- and mass cytometry, pre-clinical proton therapy and imaging (incl. animal MRI) and electron-, confocal- and high-resolution microscopy. The Institute’s Annual Report can be downloaded at Annual reports.
 
The mission of Department of Radiation Biology is to improve the outcome of cancer treatment by radiation-based strategies. We are an interdisciplinary team of approximately 50 employees consisting of physicists, molecular biologists, biochemists, pharmacists, medical doctors and engineers, organized in 5 research groups and 3 project groups. The research at the department is focused on the biological responses to ionizing and non-ionizing radiation. Our vision is to understand responses to ionizing and non-ionizing radiation on the molecular, cellular and physiological level, and utilize this knowledge to improve cancer outcomes with new biomarkers, therapies, and technologies. Our research efforts involve basic, translational and clinical radiobiological research as well as pursuing innovations for improved radioterapeutic outcome.
 
The research activity at the Department of Radiation Biology includes a research group within the field of photobiology and photomedicine with a focus on photochemical internalization (PCI) for light-directed intracellular delivery of medicines for treatment of cancer. The current group leader will soon retire and we are seeking a highly motivated and enthusiastic researcher for a tenured Group Leader position to continue and expand this field of research. The candidate will be selected based on evaluation of how the applicant’s research profile complements and strengthens the Department’s profile.
 

Oslo University Hospital is a workplace with great diversity. We believe this is essential to perform the tasks required of us. Therefore, we pursue diversity among our job applicants and encourage everyone to apply regardless of who you are and what background you have
 

Kvalifikasjoner:

• PhD degree in natural sciences or medicine
• At least 6 years of experience from biomedical radiation research in accordance with the job description
• Experience in photomedicine is a prerequisite, while experience in immunology and drug delivery is an advantage
• Scientific qualifications at or near the professorial level
• Experience with and willingness to build own research group
• Documentation of successful funding of own research
• Experience from supervision at the MSc and PhD level is a prerequisite, while experience with and training in leadership is an advantage

Personlige egenskaper:

• Team player
• Flexible
• Self-motivated
• Communicative
• Leadership and organization skills

Vi tilbyr:

• The successful candidate will be offered a permanent position internally funded by OUH. The researcher position will according to Norwegian legislation be subjected to a 6 month probationary period. The position is included in the Norwegian Health Assurance and Retirement Pension Schemes, and the salary will be within the official range at OUH for group leader positions depending on qualifications.
• An enthusiastic work environment
• An environment with broad expertise and high professional level
• Access to high quality instrumentation and services from the Core Facility Department and other in-house instrumentation, such as a preclinical research facility , MRI, X-ray sources for in vitro and in vivo studies, hypoxia-chamber, IVIS, Seahorse and more.
• A preclinical proton research facility will be available from 2025.

 

The application should include (as one combined pdf file) a cover letter summarizing the career and past research and innovation portfolio, CV with a full list of publications with the 10 most significant indicated and a research plan (2-3 pages) for the first 5 years. The CV should include a list of supervised PhD candidates (name of candidate, period of supervision, institution, date of defense of the thesis, main- and co supervisors for each candidate), ability to raise funding of own research, administrative experience, leadership, collaborations, communication and dissemination. The applicant is expected to present a plan on how his/her research will integrate and synergize with the ongoing research at the department and with the environment at the ICR and at OUH Comprehensive Cancer Centre at large as described: Dept. of Radiation Biology; Institute for Cancer Research; OUS Research.